Dolby Laboratories, Inc. (DLB)

NYSE: DLB · Real-Time Price · USD

62.10

+0.33 (0.53%)

At close: Aug 10, 2026, 4:00 PM EDT

61.59

-0.51 (-0.82%)

Pre-market: Aug 11, 2026, 7:19 AM EDT

Dolby Laboratories Balance Sheet

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 26, 2026	Sep '25 Sep 26, 2025	Sep '24 Sep 27, 2024	Sep '23 Sep 29, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 24, 2021
Cash & Equivalents	669.39	701.89	482.05	745.36	620.13	1,225
Short-Term Investments	0.65	0.7	-	139.15	189.21	38.84
Cash & Short-Term Investments	670.05	702.6	482.05	884.51	809.34	1,264
Cash Growth	-4.19%	45.75%	-45.50%	9.29%	-35.98%	13.00%
Accounts Receivable	285.15	331.1	315.46	262.25	243.59	232.61
Other Receivables	206.88	180.89	197.48	182.13	176.09	182.32
Total Trade Receivables	492.03	511.99	512.93	444.38	419.69	414.93
Inventory	30.77	30.42	33.73	35.62	23.55	10.97
Other Current Assets	133.2	143.34	165.7	123.29	58.32	70.39
Total Current Assets	1,326	1,388	1,194	1,488	1,311	1,760
Net Property, Plant & Equipment	501.52	563.81	579.01	521.78	560.01	601.51
Other Intangible Assets	382.43	354.33	414.51	167.43	112.27	122.89
Goodwill	528.34	529.9	533.21	408.41	365.15	340.69
Long-Term Investments	86.44	87.21	89.29	97.81	102.51	62.82
Other Long-Term Assets	331.83	304.17	299.4	296.53	238.72	217.28
Total Assets	3,157	3,228	3,110	2,980	2,690	3,106
Accounts Payable	12.47	17.84	17.38	20.93	14.17	17.78
Accrued Expenses	360.41	369.26	347.53	351.4	230.24	262.73
Current Portion of Leases	9.86	10.38	12.24	13.63	13.26	15.4
Unearned Revenue	33.59	31.38	31.64	31.51	18.59	18.47
Other Current Liabilities	-	8.93	9.05	4.77	1.27	1.33
Total Current Liabilities	416.33	437.79	417.84	422.23	277.52	315.72
Long-Term Leases	37.59	28.49	34.79	37.02	37.69	56.72
Other Long-Term Liabilities	109.97	129.53	170.41	148.34	123.33	129.02
Total Long-Term Liabilities	147.56	158.02	205.2	185.36	161.01	185.74
Total Liabilities	563.89	595.81	623.03	607.58	438.53	501.46
Common Stock	0.09	0.09	0.09	0.09	0.09	0.1
Accumulated Other Comprehensive Income	-15.47	-12.52	-15.18	-36.98	-51.64	-10.03
Retained Earnings	2,599	2,635	2,496	2,392	2,298	2,608
Total Common Shareholders' Equity	2,584	2,623	2,481	2,355	2,246	2,604
Minority Interest	9.17	9.39	9.73	17.08	4.84	-
Shareholders' Equity	2,593	2,632	2,487	2,372	2,251	2,604
Total Liabilities & Equity	3,157	3,228	3,110	2,980	2,690	3,106
Total Debt	47.45	38.88	47.03	50.65	50.94	72.12
Net Cash (Debt)	622.6	663.72	435.02	833.86	758.4	1,192
Net Cash Growth	-5.70%	52.57%	-47.83%	9.95%	-36.38%	14.88%
Net Cash Per Share	6.49	6.81	4.47	8.53	7.44	11.39
Book Value	2,584	2,623	2,481	2,355	2,246	2,604
Book Value Per Share	26.92	26.90	25.49	24.10	22.03	24.89
Tangible Book Value	1,673	1,738	1,533	1,779	1,769	2,141
Tangible Book Value Per Share	17.43	17.83	15.76	18.21	17.34	20.46

SEC Filings: 10-K · 10-Q